This month, we explore the fundraising journey behind carevix®, as Aspivix CTO and co-founder Julien Finci reflects on pitching a women’s health innovation to investors – and challenging persistent misconceptions around Femtech.
A century-old gynaecological tool designed to extract bullets sparked the creation of carevix®, a gentler, suction-based alternative that’s transforming how IUD insertions are experienced by women and clinicians alike.
This January, we’re spotlighting an unsung femtech hero: Julien Finci, whose work is helping make gynaecological care gentler for millions of women.
Behind every pharma breakthrough are experts who don’t always get recognised.
As a Femtech founder, you’re short on money and time. The right agency can change that – boosting investor visibility, sharpening your business case, and creating proof points that open doors. We turn your ‘someday’ list into progress today.
Femtech is booming, but the noise is deafening. Clear, strategic content is what cuts through.
Women’s health still faces a huge knowledge gap. Find out how to get your FemTech mission the funding it deserves.
In recent years, there has been a surge of interest and investment in femtech – technology aiming to address the historical neglect of women’s healthcare
Only those who are capable of silliness can be called truly intelligent.
